144 related articles for article (PubMed ID: 33441470)
1. Tip of the iceberg: a tertiary care centre retrospective study of left ventricular hypertrophy aetiologies.
Beneyto M; Cariou E; Brunel J; Scripcariu A; Delasnerie H; Brun S; Lavie-Badie Y; Dupin Deguine D; Galinier M; Carrié D; Lairez O
Open Heart; 2021 Jan; 8(1):. PubMed ID: 33441470
[TBL] [Abstract][Full Text] [Related]
2. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
[TBL] [Abstract][Full Text] [Related]
3. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
Sipola P; Magga J; Husso M; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Eur Radiol; 2011 Jul; 21(7):1383-9. PubMed ID: 21274714
[TBL] [Abstract][Full Text] [Related]
4. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
Alame AJ; Garg S; Kozlitina J; Ayers C; Peshock RM; Matulevicius SA; Drazner MH
JAMA Cardiol; 2018 Dec; 3(12):1167-1173. PubMed ID: 30427995
[TBL] [Abstract][Full Text] [Related]
5. Texture analysis of cardiovascular magnetic resonance cine images differentiates aetiologies of left ventricular hypertrophy.
Schofield R; Ganeshan B; Fontana M; Nasis A; Castelletti S; Rosmini S; Treibel TA; Manisty C; Endozo R; Groves A; Moon JC
Clin Radiol; 2019 Feb; 74(2):140-149. PubMed ID: 30527518
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic strain in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy.
Sun JP; Xu TY; Ni XD; Yang XS; Hu JL; Wang SC; Li Y; Bahler RC; Wang JG
Echocardiography; 2019 Feb; 36(2):257-265. PubMed ID: 30561121
[TBL] [Abstract][Full Text] [Related]
7. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
8. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
[TBL] [Abstract][Full Text] [Related]
9. Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy.
Arenja N; Fritz T; Andre F; Riffel JH; Aus dem Siepen F; Ochs M; Paffhausen J; Hegenbart U; Schönland S; Müller-Hennessen M; Giannitsis E; Kristen AV; Katus HA; Friedrich MG; Buss SJ
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1414-1422. PubMed ID: 28165128
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).
Pouleur AC; Anker S; Brito D; Brosteanu O; Hasenclever D; Casadei B; Edelmann F; Filippatos G; Gruson D; Ikonomidis I; Lhommel R; Mahmod M; Neubauer S; Persu A; Gerber BL; Piechnik S; Pieske B; Pieske-Kraigher E; Pinto F; Ponikowski P; Senni M; Trochu JN; Van Overstraeten N; Wachter R; Balligand JL
ESC Heart Fail; 2018 Oct; 5(5):830-841. PubMed ID: 29932311
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
12. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes.
Sharma S; Elliott PM; Whyte G; Mahon N; Virdee MS; Mist B; McKenna WJ
J Am Coll Cardiol; 2000 Sep; 36(3):864-70. PubMed ID: 10987612
[TBL] [Abstract][Full Text] [Related]
13. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
[TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study.
Grover S; Lloyd R; Perry R; Lou PW; Haan E; Yeates L; Woodman R; Atherton JJ; Semsarian C; Selvanayagam JB
Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):932-938. PubMed ID: 30668650
[TBL] [Abstract][Full Text] [Related]
17. Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction.
Stiermaier T; Pöss J; Eitel C; de Waha S; Fuernau G; Desch S; Thiele H; Eitel I
Clin Res Cardiol; 2018 Nov; 107(11):1013-1020. PubMed ID: 29766285
[TBL] [Abstract][Full Text] [Related]
18. Vigorous exercise in patients with hypertrophic cardiomyopathy.
Dejgaard LA; Haland TF; Lie OH; Ribe M; Bjune T; Leren IS; Berge KE; Edvardsen T; Haugaa KH
Int J Cardiol; 2018 Jan; 250():157-163. PubMed ID: 29169752
[TBL] [Abstract][Full Text] [Related]
19. Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy.
Phelan D; Thavendiranathan P; Popovic Z; Collier P; Griffin B; Thomas JD; Marwick TH
J Am Soc Echocardiogr; 2014 Aug; 27(8):888-95. PubMed ID: 24874973
[TBL] [Abstract][Full Text] [Related]
20. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
